About Scilla Biotechnologies Limited
Data last updated:
Scilla Biotechnologies Limited is a public limited company based in New Delhi, Delhi, India. It operates in the real estate financing segment of the financial services sector. It was incorporated on 13 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PLC129869. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It was formerly known as Scilla Biotechnologies Private Limited. It is led by directors including Arun Kumar Sharma and Nupur Singh.
Its last annual general meeting (AGM) was held on 14 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 301 Iiird Floor Balaji Plaza Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087.
Court records list 3 cases involving the company, including 3 filed against it.
For more details, the company can be reached via its website scillabiotech.com.
Company details
CIN history
Scilla Biotechnologies has one previous CIN (Corporate Identification Number): U24232DL2004PTC129869. The current CIN is U24232DL2004PLC129869, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL2004PLC129869 | Current |
| U24232DL2004PTC129869 | Previous |
Contact details
Scilla Biotechnologies Limited's registered office is in New Delhi, Delhi. Its website is scillabiotech.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address301 Iiird Floor Balaji Plaza Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087
- IndustryFinancial Services, Real Estate Financing
To see the full contact details of Scilla Biotechnologies Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Scilla Biotechnologies Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scilla Biotechnologies Limited, buy the company report.
Board of directors of Scilla Biotechnologies Limited
Scilla Biotechnologies has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Kumar Sharma | Director | 07 Feb 2008 | 18 Years 8 Months | Current |
| Nupur Singh | Director | 13 Oct 2004 | 22 Years 0 Months | Current |
| Amit Kumar Singh Also directs: BVM Pharma Limited | Director | 13 Oct 2004 | 22 Years 0 Months | Current |
Auditor
Scilla Biotechnologies Limited is audited by M/S SUMIT GARG & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/S SUMIT GARG & CO. | FY 2023 | 020760C |
Shareholding
The shareholding of Scilla Biotechnologies Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Scilla Biotechnologies Limited, buy the company report.
Legal cases
Scilla Biotechnologies Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Execution petition | Filed against the company by Reliance Capital Limited | Disposed |
| High Court of Delhi | Court case (EX.P.) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Lilly Icos LLC & Another | Disposed |
To see the full case history of Scilla Biotechnologies Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scilla Biotechnologies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Scilla Biotechnologies has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Scilla Biotechnologies Limited, buy the company report.
Recent activity
Scilla Biotechnologies Limited has 3 board changes on record since 2004: 3 appointments. The latest: Arun Kumar Sharma was appointed as Director on 07 Feb 2008.
Frequently asked questions
Scilla Biotechnologies is an active public limited company based in New Delhi, Delhi, India. The company works in real estate financing, within the financial services industry. It was incorporated on 13 October 2004 (22+ years old) and is registered under CIN U24232DL2004PLC129869.
Scilla Biotechnologies has 3 current directors:
- Arun Kumar Sharma - Director
- Nupur Singh - Director
- Amit Kumar Singh - Director
The latest financial statements of Scilla Biotechnologies on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 14 August 2023. Year-wise statements from 2015 are in the company report.
No. Scilla Biotechnologies has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Scilla Biotechnologies is U24232DL2004PLC129869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scilla Biotechnologies has 3 court cases on record: 3 filed against it. Most are in the high courts.
Scilla Biotechnologies was incorporated on 13 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Arun Kumar Sharma was appointed as Director on 07 Feb 2008. Amit Kumar Singh was appointed as Director on 13 Oct 2004. Nupur Singh was appointed as Director on 13 Oct 2004.
Scilla Biotechnologies can be reached through the website scillabiotech.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Scilla Biotechnologies is at 301 Iiird Floor Balaji Plaza Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
